Intensive induction chemotherapy vs hypomethylating agent–based regimen in patients aged ≥70 years with newly diagnosed acute myeloid leukemia

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles